Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Avian Dis ; 38(3): 483-93, 1994.
Article in English | MEDLINE | ID: mdl-7832701

ABSTRACT

Coccidia were isolated from 122 Belgian broiler farms without clinical coccidiosis. Shuttle programs including robenidin or nicarbazine in the starter (7-14 days) followed by an ionophore or diclazuril in the grower ration were most commonly used. Out of 215 coccidiosis-positive groups, 146 Eimeria acervulina, 65 E. maxima, and 88 E. tenella isolates were tested without further laboratory propagation in 17 sensitivity profiles. For each profile, oocytes were pooled from 9 +/- 4 farms (mean +/- SD) that used the same anticoccidial program and that belonged to the same integrated broiler operation. Each suspension contained an equal number of isolates and oocyst numbers from each farm tested. Each profile included an unmedicated uninfected group, an unmedicated infected group, and 11 medicated infected groups, consisting each of three replicates of three Ross chicks. Medication started at 8 days of age, and each inoculated bird received 50,000 sporulated oocysts at 10 days. Results were related to the anticoccidial program that had been in use. Chemical drugs showed the highest activity against Eimeria, whereas ionophores were less efficacious. Of the latter, monensin (110 ppm) was least active; narasin (70 ppm), salinomycin (60 ppm), and maduramicin (5 ppm) took an intermediate position, and lasalocid (90 ppm) was most active. A 50% improvement in weight gain was obtained in 7 to 10 out of 17 profiles with 100 + 8.35 ppm clopidol/methylbenzoquate (10), 125 ppm nicarbazin (9), 3 ppm halofuginone (8), and 1 ppm diclazuril (7). A 50% improvement in feed conversion was obtained in 7 to 11 profiles with nicarbazin (11), halofuginone (10), diclazuril (9), 33 ppm robenidine (9), clopidol/methylbenzoquate (7), and lasalocid (7). Based on relative oocyst output, the highest activity against E. acervulina was obtained with clopidol/methylbenzoquate (8/16); the highest activity against E. maxima was obtained with lasalocid (6/6), diclazuril (5/6), and halofuginone (5/6); and the highest activity against E. tenella was obtained with diclazuril (8/8), amprolium/ethopabate (5/8), halofuginone (4/8), maduramicin (4/8), and nicarbazin (4/8).


Subject(s)
Chickens/parasitology , Coccidiostats/pharmacology , Eimeria/drug effects , Animal Husbandry , Animals , Belgium , Coccidiosis/drug therapy , Coccidiosis/pathology , Coccidiosis/veterinary , Drug Evaluation, Preclinical , Drug Resistance , Eimeria/isolation & purification , Ionophores/pharmacology , Nitriles/pharmacology , Poultry Diseases/drug therapy , Poultry Diseases/pathology , Triazines/pharmacology , Weight Gain
2.
Vet Q ; 9(1): 9-14, 1987 Jan.
Article in English | MEDLINE | ID: mdl-3031869

ABSTRACT

Intratracheal inoculation of 2 Belgian H3N2-influenza viral strains, isolated from sick swine in the field, caused high fever, anorexia and dyspnoea in unvaccinated swine. The strains are related to the human A/Port Chalmers/1/73 (H3N2)-strain. In a limited study, 2 subunit vaccines, both derived from the human A/Philippines/2/82 (H3N2)-strain, were tested for efficacy in protecting swine against these Belgian field isolates. Vaccine A was a commercial vaccine, vaccine B an experimental vaccine. For evaluation of the efficacy of the vaccines, clinical as well as virological parameters were used. It was found that 2 spaced injections of the experimental vaccine (B) resulted in very high serum hemagglutination-inhibition (HI) titres against the Philippines-strain. Nevertheless, only partial protection was obtained, as indicated by the milder clinical signs and the decreased viral replication at challenge. One injection of the experimental vaccine (B) and 2 spaced injections of the commercial vaccine (A) did not result in any protection at challenge, even though moderate HI titres against the Philippines-strain were obtained. It was concluded that if an H3N2-strain is included in vaccines for use in swine, a strain should be selected which is identical or very closely related to the strain(s) prevalent in the swine population of the country in which the vaccine will be used.


Subject(s)
Antibodies, Viral/biosynthesis , Influenza A Virus, H3N2 Subtype , Influenza A virus/immunology , Influenza Vaccines/immunology , Orthomyxoviridae Infections/veterinary , Swine Diseases/immunology , Animals , Fluorescent Antibody Technique , Hemagglutination Inhibition Tests , Humans , Orthomyxoviridae Infections/immunology , Swine , Vaccination/veterinary
3.
Avian Dis ; 28(2): 319-22, 1984.
Article in English | MEDLINE | ID: mdl-6743170

ABSTRACT

Newcastle disease virus was isolated from six field cases in Morocco. On the basis of the mean death time of chicken embryos, the intracerebral pathogenicity index, and plaque formation on chicken embryo fibroblast monolayers, five isolates were determined to be of the velogenic pathotype. One of these differed from the others in that it agglutinated equine erythrocytes. The sixth isolate was found to be of low virulence but differed from the vaccinal strain tested.


Subject(s)
Chickens/microbiology , Newcastle Disease/microbiology , Newcastle disease virus/isolation & purification , Animals , Chick Embryo , Morocco , Newcastle disease virus/classification , Newcastle disease virus/pathogenicity , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...